{
    "Title": "Leishmania donovani Argininosuccinate Synthase Is an Active Enzyme Associated with Parasite Pathogenesis",
    "URL": "https://doi.org/10.1371/journal.pntd.0001849",
    "Published": "October 18, 2012",
    "Subject_Areas": [
        "Asses",
        "Leishmania",
        "Parasitic diseases",
        "Leishmania donovani",
        "Amastigotes",
        "Cellular structures and organelles",
        "Enzyme-linked immunoassays",
        "Recombinant proteins"
    ],
    "Authors": {
        "Ines Lakhal-Naouar": [
            "Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Bethesda, Maryland, United States of America"
        ],
        "Armando Jardim": [
            "Institute of Parasitology, McGill University and the Centre for Host-Parasite Interactions, Quebec, Canada"
        ],
        "Rona Strasser": [
            "Institute of Parasitology, McGill University and the Centre for Host-Parasite Interactions, Quebec, Canada"
        ],
        "Shen Luo": [
            "Laboratory of Chemistry, Division of Therapeutic Proteins, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Bethesda, Maryland, United States of America"
        ],
        "Yukiko Kozakai": [
            "Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Bethesda, Maryland, United States of America"
        ],
        "Hira L. Nakhasi": [
            "Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Bethesda, Maryland, United States of America"
        ],
        "Robert C. Duncan": [
            "Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Bethesda, Maryland, United States of America"
        ]
    }
}